导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.36% | 2908/4773 |
| 近一周 | -2.76% | 3015/5462 |
| 近一月 | - | 693/5421 |
| 近一季 | -2.03% | 1141/5209 |
| 近半年 | -6.54% | 3103/4920 |
| 近一年 | -1.10% | 2831/4366 |
| 近两年 | 37.17% | 2008/2954 |
| 近三年 | 42.91% | 657/2253 |
| 成立以来 | 32.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.58% 1240/4961 |
-10.37% 4094/5312 |
- - |
- - |
| 2025 | 22.87% 1931/4813 |
2.40% 1386/3635 |
9.71% 272/4076 |
5.25% 3597/4524 |
3.92% 597/4813 |
| 2024 | 21.71% 403/3463 |
0.11% 1041/2808 |
9.38% 50/3014 |
8.46% 2747/3129 |
2.49% 939/3463 |
| 2023 | 1.71% 349/2656 |
5.79% 754/2280 |
2.92% 116/2385 |
-6.02% 1412/2515 |
-0.60% 231/2655 |
| 2022 | -1.07% 45/2207 |
-1.36% 144/1919 |
3.49% 1144/2016 |
-11.08% 491/2113 |
9.00% 244/2208 |
| 2021 | 8.84% 469/1822 |
12.73% 16/1255 |
0.33% 1105/1330 |
1.13% 456/1466 |
-4.84% 1498/1822 |
| 2020 | -21.35% 1008/1250 |
-17.91% 1000/1028 |
-0.79% 1025/1067 |
-6.79% 1127/1164 |
3.62% 899/1184 |
| 2019 | 3.36% 802/1092 |
7.46% 729/739 |
-3.79% 403/788 |
-6.63% 814/850 |
7.08% 488/918 |
| 2018 | -5.15% 60/834 |
- - |
0.57% 29/631 |
4.26% 73/660 |
-6.53% 48/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 摩根标普港股通低波红利指数A VS. 长安沪深300非周期A(740101) |